StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) KPIs and segments

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.13−0.05 (-4.24%)

Close on Nov 17, 2026Market cap $5.45MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Alzamend Neuro's business

Coming soon

This tab will track the numbers specific to Alzamend Neuro's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?